Endologix, Inc. (ELGX) - Product Pipeline Analysis

GlobalData, April 2012, Pages: 42

Endologix, Inc. (ELGX) - Product Pipeline Analysis

Summary

Endologix, Inc. (Endologix) is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). Its Powerlink Delivery System is an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA; and has certain advantages when compared to marketed stent alternatives. The company has 21 US patents issued, 24 pending US applications, and 22 foreign patents in the area of aorta treatment. Endologix's current aorta treatment is related to patents that have expiration dates from 2017 to 2023.

This report is a source for data, analysis and actionable intelligence on the Endologix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
Endologix, Inc. - Business Description
Key Facts
Endologix, Inc. - Major Products and Services
Endologix, Inc. Pipeline Products by Equipment Type
Endologix, Inc. Pipeline Products by Development Stage
Endologix, Inc. Pipeline Products by Therapy Area
Endologix, Inc. Pipeline Products by Trial Phase
Endologix, Inc. Pipeline Products by Milestone Summary
AFX II
AFX II Product Status
AFX II Product Description
Baraitric Stent
Baraitric Stent Product Status
Baraitric Stent Product Description
IntuiTrak Delivery System
IntuiTrak Delivery System Product Status
IntuiTrak Delivery System Product Description
IntuiTrak Delivery System Product Milestone
IntuiTrak Delivery System Product Patent Details
IntuiTrak Endovascular Delivery System - PEVAR
IntuiTrak Endovascular Delivery System - PEVAR Product Status
IntuiTrak Endovascular Delivery System - PEVAR Product Description
IntuiTrak Endovascular Delivery System - PEVAR Product Milestone
Nellix AAA Endovascular System
Nellix AAA Endovascular System Product Status
Nellix AAA Endovascular System Product Description
Nellix AAA Endovascular System Product Milestone
Ventana Fenestrated Stent Graft
Ventana Fenestrated Stent Graft Product Status
Ventana Fenestrated Stent Graft Product Description
Ventana Fenestrated Stent Graft Product Milestone
Xpand Balloon Expandable Covered Stent
Xpand Balloon Expandable Covered Stent Product Status
Xpand Balloon Expandable Covered Stent Product Description
Endologix, Inc. - Key Competitors
Endologix, Inc. - Key Employees
Endologix, Inc. - Key Employee Biographies
Endologix, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Endologix, Inc., Recent Developments
Mar 28, 2012: Endologix Announces Retirement Of Franklin D Brown As Chairman
Feb 22, 2012: Endologix Reports Revenue Of $83.4m In 2011
Oct 27, 2011: Endologix Reports Revenues Of $22.3m In Q3 2011
Aug 30, 2011: Endologix Appoints Ruth Lyons As Vice President, Global Marketing
Aug 18, 2011: Cook Medical Remains Resolute In Pursuit Of Infringement Action Against Endologix Following Markman Ruling
Aug 17, 2011: Endologix Announces Favorable Markman Ruling In Cook Patent Litigation
Jul 21, 2011: Endologix Reports Total Revenue Of $19.2m In Q2 2011
Jul 18, 2011: Endologix And LeMaitre Vascular Enter Into Early Termination Agreement For European Distribution Rights Of Endologix Products
Jun 15, 2011: Endologix To Highlight Complete Product Portfolio At SVS Annual Meeting In New Illinois
Apr 21, 2011: Endologix Reports Total Revenue Of $18.5m In Q1 2011
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Endologix, Inc., Key Facts
Endologix, Inc. Key Pipeline Products by Equipment Type
Endologix, Inc. Key Pipeline Products by Therapy Area
Endologix, Inc. Key Pipeline Products by Development Stage
Endologix, Inc. Key Pipeline Products by Trial Phase
Endologix, Inc., Key Facts
Endologix, Inc., Major Products and Services
Endologix, Inc. Number of Pipeline Products by Equipment Type
Endologix, Inc. Pipeline Products by Equipment Type
Endologix, Inc. Number of Pipeline Products by Development Stage
Endologix, Inc. Pipeline Products by Development Stage
Endologix, Inc. Number of Pipeline Products by Therapy Area
Endologix, Inc. Pipeline Products by Therapy Area
Endologix, Inc. Number of Pipeline Products by Trial Phase
Endologix, Inc. Pipeline Products by Trial Phase
Endologix, Inc. Number of Pipeline Products By Milestone Summary
Endologix, Inc. Pipeline Products by Milestone Summary
AFX II - Product Status
AFX II - Product Description
Baraitric Stent - Product Status
Baraitric Stent - Product Description
IntuiTrak Delivery System - Product Status
IntuiTrak Delivery System - Product Description
IntuiTrak Delivery System - Product Milestone
IntuiTrak Delivery System - Patent Details
IntuiTrak Endovascular Delivery System - PEVAR - Product Status
IntuiTrak Endovascular Delivery System - PEVAR - Product Description
IntuiTrak Endovascular Delivery System - PEVAR - Product Milestone
Nellix AAA Endovascular System - Product Status
Nellix AAA Endovascular System - Product Description
Nellix AAA Endovascular System - Product Milestone
Ventana Fenestrated Stent Graft - Product Status
Ventana Fenestrated Stent Graft - Product Description
Ventana Fenestrated Stent Graft - Product Milestone
Xpand Balloon Expandable Covered Stent - Product Status
Xpand Balloon Expandable Covered Stent - Product Description
Endologix, Inc., Key Employees
Endologix, Inc., Key Employee Biographies
Endologix, Inc., Subsidiaries

List of Figures
Endologix, Inc. Key Pipeline Products by Equipment Type
Endologix, Inc. Pipeline Products by Equipment Type
Endologix, Inc. Pipeline Products by Development Stage
Endologix, Inc. Pipeline Products by Therapy Area
Endologix, Inc. Pipeline Products by Trial Phase
Endologix, Inc. Pipeline Products by Milestone Summary

JOTEC GmbH
Bolton Medical, Inc.
St. Jude Medical, Inc.
VASCUTEK Ltd
Cordis Corporation
Lombard Medical Technologies PLC
Aptus Endosystems, Inc.
TriVascular, Inc.
Medtronic, Inc.
Cook Medical Incorporated
W. L. Gore & Associates, Inc.

Customers who bought this item also bought

• Top Five Global Electric Vehicle Companies: Performance, Strategies and Competitive Analysis
• General Motors Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• American Tire Distributors Holdings, Inc. - Strategic SWOT Analysis Review
• Supplying Chrysler
• Supplying Ford 2012
• Ford Motor Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Global Automotive Head-up Display Market 2012-2016
• Global Friction Products Market 2012-2016
• American Axle & Manufacturing Holdings, Inc. (AXL) - Financial and Strategic SWOT Analysis Review
• Supplying the Volkswagen Group